GCP
GSA Capital Partners Portfolio holdings
AUM
$1.43B
1-Year Return
20.34%
This Quarter Return
+0.8%
1 Year Return
+20.34%
3 Year Return
+63.52%
5 Year Return
+120%
10 Year Return
+237.47%
AUM
$796M
AUM Growth
-$185M
(-19%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-23.37%
Top 10 Holdings %
Top 10 Hldgs %
3.37%
Holding
1,987
New
623
Increased
339
Reduced
393
Closed
624
Top Buys
| 1 |
Calix
CALX
|
+$2.74M |
| 2 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$2.58M |
| 3 |
Genius Sports
GENI
|
+$2.45M |
| 4 |
PRTY
Party City Holdco Inc.
PRTY
|
+$2.4M |
| 5 |
nVent Electric
NVT
|
+$2.32M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$5.41M |
| 2 |
Morgan Stanley
MS
|
+$5.34M |
| 3 |
Openlane
KAR
|
+$4.6M |
| 4 |
Apple
AAPL
|
+$4.51M |
| 5 |
Herc Holdings
HRI
|
+$4.09M |
Sector Composition
| 1 | Healthcare | 16.21% |
| 2 | Industrials | 15.47% |
| 3 | Technology | 14.9% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Financials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Viking Therapeutics
VKTX
$2.91B
| $353K | 0.04% |
76,700
+23,122
| +43% | +$106K |
|
827
V2X
VVX
$1.73B
| $353K | 0.04% |
+7,718
| New | +$353K |
|
828
Oric Pharmaceuticals
ORIC
$1.05B
| $352K | 0.04% |
+23,954
| New | +$352K |
|
829
Vistra
VST
$70.8B
| $352K | 0.04% |
15,458
-253
| -2% | -$5.76K |
|
|
GOOD
830
Gladstone Commercial Corp
GOOD
$601M
| $351K | 0.04% |
+13,628
| New | +$351K |
|
831
Digital Turbine
APPS
$484M
| $350K | 0.04% |
+5,739
| New | +$350K |
|
832
AeroVironment
AVAV
$12.6B
| $350K | 0.04% |
+5,646
| New | +$350K |
|
833
Cincinnati Financial
CINF
$24.1B
| $350K | 0.04% |
+3,071
| New | +$350K |
|
834
Crinetics Pharmaceuticals
CRNX
$3.19B
| $350K | 0.04% |
12,335
-4,145
| -25% | -$118K |
|
835
OGE Energy
OGE
$8.89B
| $349K | 0.04% |
9,092
-40,945
| -82% | -$1.57M |
|
836
Anika Therapeutics
ANIK
$123M
| $348K | 0.04% |
9,717
-9,704
| -50% | -$348K |
|
837
Carriage Services
CSV
$655M
| $348K | 0.04% |
5,404
-11,976
| -69% | -$771K |
|
838
FormFactor
FORM
$2.33B
| $348K | 0.04% |
+7,619
| New | +$348K |
|
839
Ryerson Holding
RYI
$724M
| $348K | 0.04% |
13,354
+1,101
| +9% | +$28.7K |
|
840
Boston Omaha
BOC
$422M
| $347K | 0.04% |
+12,061
| New | +$347K |
|
841
Credit Acceptance
CACC
$5.85B
| $347K | 0.04% |
+504
| New | +$347K |
|
|
TCRR
842
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $347K | 0.04% |
74,402
+823
| +1% | +$3.84K |
|
|
EVFM
843
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $347K | 0.04% |
61,652
+57,627
| +1,432% | +$324K |
|
844
Affiliated Managers Group
AMG
$6.72B
| $346K | 0.04% |
+2,106
| New | +$346K |
|
845
Immunovant
IMVT
$2.85B
| $346K | 0.04% |
40,654
-40,516
| -50% | -$345K |
|
846
SITE Centers
SITC
$473M
| $345K | 0.04% |
+27,945
| New | +$345K |
|
847
StoneX
SNEX
$5.1B
| $344K | 0.04% |
12,623
-8,093
| -39% | -$221K |
|
848
iShares Expanded Tech Sector ETF
IGM
$8.97B
| $343K | 0.04% |
4,692
-1,170
| -20% | -$85.5K |
|
849
Vertex Pharmaceuticals
VRTX
$101B
| $343K | 0.04% |
1,564
-895
| -36% | -$196K |
|
850
Vanguard Large-Cap ETF
VV
$45.2B
| $343K | 0.04% |
1,553
-510
| -25% | -$113K |
|